Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia

Clinical trial NCT05299554 · COMPLETED

Trial details

NCT number: NCT05299554
Sponsor: Immedica Pharma AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Adrenal Hyperplasia

Start date: 2022-04-01
Primary completion: 2026-01-15
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.